
AMP3D
AMP3D’s extensible SaaS platform for predictive analytics processes “Big physiological monitoring Data in real time.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | Acquisition | ||
Total Funding | 000k |
Related Content
AMP3D, a subsidiary of Nihon Kohden Digital Health Solutions, Inc., specializes in predictive analytics for continuous patient monitoring. The company operates in the healthcare technology market, providing solutions that integrate live data streams from bedside monitoring networks and electronic health records. These data are processed using patented algorithms to deliver actionable insights and intuitive visualizations. AMP3D's core product, the CoMET platform, offers a comprehensive view of patient trajectories, assessing and managing both patient and provider risk. The platform is designed to improve clinical outcomes by enabling proactive care, reducing morbidity and mortality rates, and lowering hospital stay durations and associated costs. AMP3D primarily serves hospitals and healthcare providers, aiming to enhance clinical decision support and clinical surveillance. The business model revolves around selling and licensing its proprietary software solutions to healthcare institutions, generating revenue through subscription fees and service contracts.
Keywords: predictive analytics, patient monitoring, healthcare technology, clinical decision support, electronic health records, proactive care, morbidity reduction, mortality reduction, hospital cost reduction, CoMET platform.